Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Rheumatoid Arthritis Fibroblast-like Synoviocyte Suppression Mediated by PTEN Involves Survivin Gene Silencing.

Chen D, Liu D, Liu D, He M, Peng A, Xu J, Lin L, Luo F, Chen L, Huang X, Zhuang J, Xu J.

Sci Rep. 2017 Mar 23;7(1):367. doi: 10.1038/s41598-017-00517-w.

2.

Investigation of MMP-1 genetic polymorphisms and protein expression and their effects on the risk of Kashin-Beck disease in the northwest Chinese Han population.

Shi X, Lv A, Ma J, Zhang F, Wen Y, Zhang Z, Guo X.

J Orthop Surg Res. 2016 May 31;11(1):64. doi: 10.1186/s13018-016-0398-6.

3.

Matrix Metalloproteinase-3 -1171 5A/6A Polymorphism (rs35068180) is Associated with Risk of Periodontitis.

Ding C, Chen X, Zhang PT, Huang JP, Xu Y, Chen N, Zhong LJ.

Sci Rep. 2015 Jun 30;5:11667. doi: 10.1038/srep11667.

4.

Anti-arthritic activity of Fu-Fang-Lu-Jiao-Shuang on collagen-induced arthritis in Balb/c mice and its underlying mechanisms.

Wang Y, Sun W, Chen L, Xu X, Wu Y, Zhang J, Zhang Y.

Pharmacogn Mag. 2015 Apr-Jun;11(42):242-9. doi: 10.4103/0973-1296.153065.

5.

Lack of association of matrix metalloproteinase-3 gene polymorphism with susceptibility to rheumatoid arthritis: a meta-analysis.

Feng Z, He G, Chen Z, Wu Z, Li J.

BMC Musculoskelet Disord. 2014 Nov 18;15:376. doi: 10.1186/1471-2474-15-376.

6.

Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation.

Kauwe JS, Bailey MH, Ridge PG, Perry R, Wadsworth ME, Hoyt KL, Staley LA, Karch CM, Harari O, Cruchaga C, Ainscough BJ, Bales K, Pickering EH, Bertelsen S; Alzheimer's Disease Neuroimaging Initiative, Fagan AM, Holtzman DM, Morris JC, Goate AM.

PLoS Genet. 2014 Oct 23;10(10):e1004758. doi: 10.1371/journal.pgen.1004758. eCollection 2014 Oct.

7.

Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma.

Stott-Miller M, Houck JR, Lohavanichbutr P, Méndez E, Upton MP, Futran ND, Schwartz SM, Chen C.

Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2628-36. doi: 10.1158/1055-9965.EPI-11-0503. Epub 2011 Sep 29.

8.

Negative association of the chemokine receptor CCR5 d32 polymorphism with systemic inflammatory response, extra-articular symptoms and joint erosion in rheumatoid arthritis.

Rossol M, Pierer M, Arnold S, Keysser G, Burkhardt H, Baerwald C, Wagner U.

Arthritis Res Ther. 2009;11(3):R91. doi: 10.1186/ar2733. Epub 2009 Jun 18.

9.

No association between matrix metalloproteinase-1 or matrix metalloproteinase-3 polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study.

Beeghly-Fadiel A, Cai Q, Lu W, Long J, Gao YT, Shu XO, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1324-7. doi: 10.1158/1055-9965.EPI-09-0046. Epub 2009 Mar 24. No abstract available.

10.

Progress in matrix metalloproteinase research.

Murphy G, Nagase H.

Mol Aspects Med. 2008 Oct;29(5):290-308. doi: 10.1016/j.mam.2008.05.002. Epub 2008 May 24. Review.

11.

Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets.

van der Helm-van Mil AH, Huizinga TW.

Arthritis Res Ther. 2008;10(2):205. doi: 10.1186/ar2384. Epub 2008 Mar 31. Review.

12.

MMPs as therapeutic targets--still a viable option?

Fingleton B.

Semin Cell Dev Biol. 2008 Feb;19(1):61-8. Epub 2007 Jul 6. Review.

14.

Regulatory polymorphisms in extracellular matrix protease genes and susceptibility to rheumatoid arthritis: a case-control study.

Rodriguez-Lopez J, Perez-Pampin E, Gomez-Reino JJ, Gonzalez A.

Arthritis Res Ther. 2006;8(1):R1.

Supplemental Content

Support Center